Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Neuropharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1647624

Prophylactic administration of metformin alleviates withdrawal symptoms associated with heroin

Provisionally accepted
Liu  MinghongLiu Minghong1Junyu  JiangJunyu Jiang2Xiaolong  WuXiaolong Wu3Jiaxin  LiuJiaxin Liu2Yang  LiuYang Liu2Shanshan  LingShanshan Ling2Huichun  ChenHuichun Chen1Gongliang  ZhangGongliang Zhang4Yuanhai  LiYuanhai Li5*Pang  GangPang Gang4*Xinrong  TaoXinrong Tao2*
  • 1The First Affiliated Hospital of Anhui University of Science and Technology, Huainan, China
  • 2Anhui University of Science and Technology, Huainan, China
  • 3Anhui Shendong Biotechnology Development Co., Ltd, Huainan, China
  • 4College of Basic Medical Sciences, Anhui Medical University, Hefei, China
  • 5The First Affiliated Hospital of Anhui Medical University, Hefei, China

The final, formatted version of the article will be published soon.

Objective This study aimed to evaluate whether metformin can alleviate heroin withdrawal symptoms and explore its underlying mechanisms, focusing on its reducing microglia-related neuroinflammation in the CA3 region of hippocampus. Methods We set up a heroin withdrawal mouse model by the administration of naloxone in heroin-treated mice. To reduce experimental variables, only male mice were considered in this study. The behaviors of withdrawal model mice with saline, naloxone (5 mg/kg), or metformin (100mg/kg) treatment (n= 12 for each group) were evaluated by Open Field Test (OFT) and Elevated Plus Maze Test. After the behavior tests, brain tissues were collected for histological staining experiments. Our study mainly focused on the hippocampal CA3 region. Protein expression levels of TLR4 (inflammation related) and BAX were analyzed using immunofluorescence staining. Results Metformin was proved to be capable of improving movement-related and posture-related behavioral changes caused by the naloxone-induced heroin withdrawal. Furthermore, the results of the Open-Field Test and Elevated Plus Maze test were used to demonstrate metformin's role in softening anxiety levels, which was due to its reducing microglia-related neuroinflammation in the CA3 region of hippocampus. This neuronal protection was achieved by downregulating the expression of TLR4 (inflammation related) and BAX (apoptosis marker) protein. Conclusion Overall, our data suggests that prophylactic administration of metformin has a therapeutic effect on glial-induced neuroinflammation and neuronal apoptosis in heroin withdrawal mice. Histological experiments suggested that metformin reduced microglia-mediated neuroinflammation and downregulated TLR4 and BAX expressions in the hippocampus.

Keywords: Metformin, withdrawal, Hippocampus, Behavior test, Heroin, Naloxone-induced

Received: 16 Jun 2025; Accepted: 17 Sep 2025.

Copyright: © 2025 Minghong, Jiang, Wu, Liu, Liu, Ling, Chen, Zhang, Li, Gang and Tao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yuanhai Li, liyuanhai-l@163.com
Pang Gang, panggang1975@aliyun.com
Xinrong Tao, xrtao1116@hotmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.